» Articles » PMID: 14524535

Continuous Real Time Ex Vivo Epifluorescent Video Microscopy for the Study of Metastatic Cancer Cell Interactions with Microvascular Endothelium

Overview
Specialty Oncology
Date 2003 Oct 4
PMID 14524535
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies suggest that only endothelium-attached malignant cells are capable of giving rise to hematogenous cancer metastases. Moreover, tumor cell adhesion to microvascular endothelium could be crucial in metastasis predilection to specific organs or tissues. However, the existing in vitro and in vivo techniques do not provide for sufficient delineation of distinct stages of a dynamic multi-step intravascular adhesion process. Here we report the development of an experimental system allowing for prolonged continuous ex vivo real-time observation of malignant cell adhesive interactions with perfused microvessels of a target organ in the context of its original tissue. Specifically, the vasculature of excised dura mater perfused with prostate cancer cells is described. An advantage of this technique is that selected fluorescently labeled tumor cells can be followed along identified vascular trees across the entire tissue specimen. The techniques provide for superior microvessel visualization and allow for uninterrupted monitoring and video recording of subsequent adhesion events such as rolling, docking (initial reversible adhesion), locking (irreversible adhesion), and flattening of metastatic cancer cells within perfused microvasculature on a single cell level. The results of our experiments demonstrate that intravascular adhesion of cancer cells differs dramatically from such of the leukocytes. Within dura microvessels perfused at physiological rate, non-interacting, floating, tumor cells move at velocities averaging 7.2 x 10(3) microm/s. Some tumor cells, similarly to leukocytes, exhibit rolling-like motion patterns prior to engaging into more stable adhesive interactions. In contrast, other neoplastic cells became stably adhered without rolling showing a rapid reduction in velocity from 2 x 10(3) to 0 microm/s within fractions of a second. The experimental system described herein, while developed originally for studying prostate cancer cell interactions with porcine dura mater microvasculature, offers great flexibility in adhesion experiments design and is easily adapted for use with a variety of other tissues including human.

Citing Articles

The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancer.

Murray N, Reyes E, Salazar A, Lopez M, Orrego S, Guzman E Turk J Urol. 2020; 46(3):186-195.

PMID: 32401703 PMC: 7219967. DOI: 10.5152/tud.2020.19219.


Tissue factor-expressing tumor cells can bind to immobilized recombinant tissue factor pathway inhibitor under static and shear conditions in vitro.

Che S, DeLeonardis C, Shuler M, Stokol T PLoS One. 2015; 10(4):e0123717.

PMID: 25849335 PMC: 4388665. DOI: 10.1371/journal.pone.0123717.


Pulsed estrogen therapy prevents post-OVX porcine dura mater microvascular network weakening via a PDGF-BB-dependent mechanism.

Glinskii O, Huxley V, Glinskii V, Rubin L, Glinsky V PLoS One. 2013; 8(12):e82900.

PMID: 24349391 PMC: 3857298. DOI: 10.1371/journal.pone.0082900.


Differential expression of matrix metalloproteinase-2 expression in disseminated tumor cells and micrometastasis in bone marrow of patients with nonmetastatic and metastatic prostate cancer: theoretical considerations and clinical implications-an....

Murray N, Reyes E, Tapia P, Badinez L, Orellana N Bone Marrow Res. 2012; 2012:259351.

PMID: 23227342 PMC: 3513718. DOI: 10.1155/2012/259351.


Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.

Shen Q, Lee E, Pitts R, Wu M, Yuan S Mol Cancer Res. 2010; 8(7):939-51.

PMID: 20571065 PMC: 5584073. DOI: 10.1158/1541-7786.MCR-09-0523.


References
1.
Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K . Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res. 2001; 61(5):2177-82. View

2.
Lawrence M, Springer T . Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991; 65(5):859-73. DOI: 10.1016/0092-8674(91)90393-d. View

3.
Glinsky G, Glinsky V . Apoptosis amd metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett. 1996; 101(1):43-51. DOI: 10.1016/0304-3835(96)04112-2. View

4.
Orr F, Wang H, Lafrenie R, Scherbarth S, Nance D . Interactions between cancer cells and the endothelium in metastasis. J Pathol. 2000; 190(3):310-29. DOI: 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P. View

5.
Rumbaut R, Harris N, Sial A, Huxley V, Granger D . Leakage responses to L-NAME differ with the fluorescent dye used to label albumin. Am J Physiol. 1999; 276(1):H333-9. DOI: 10.1152/ajpheart.1999.276.1.H333. View